Skip to main content

Table 3 Comparison in different cancer types between cachexia and non-cachexia cancer patients

From: Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients

 Gastric cancerColorectal cancer
 Non-cachexia (n = 126)Cachexia (n = 45)pNon-cachexia (n = 111)Cachexia (n = 29)p
Ages (years)63.27 ± 0.9264.34 ± 1.330.35261.84 ± 1.6362.21 ± 2.090.423
BMI (kg/m2)23.23 ± 0.2721.76 ± 0.470.00822.71 ± 0.3122.74 ± 0.700.965
HB (g/L)121.2 ± 2.27111.6 ± 4.360.038119.2 ± 2.64111.4 ± 4.380.147
WBC (10^9/L)5.62 ± 0.155.51 ± 0.330.7115.93 ± 0.177.04 ± 0.340.002
PLT (10^9/L)238.2 ± 7.39247.3 ± 15.070.561241.2 ± 7.83281.3 ± 18.350.023
LY (10^9/L)1.66 ± 0.051.41 ± 0.090.0121.58 ± 0.061.55 ± 0.080.793
TP (g/L)65.31 ± 0.5961.81 ± 1.030.00465.67 ± 0.5266.96 ± 1.150.252
ALB (g/L)40.53 ± 0.4438.41 ± 0.720.01941.23 ± 0.4639.10 ± 0.780.017
PA (g/L)0.219 ± 0.0050.198 ± 0.0080.0320.208 ± 0.0060.178 ± 0.0090.008
TC (mmol/L)4.18 ± 0.093.74 ± 0.140.0124.177 ± 0.104.273 ± 0.140.621
TG (mmol/L)1.35 ± 0.061.19 ± 0.110.191.23 ± 0.061.32 ± 0.090.404
ApoA (g/l)190.5 ± 18.68188.2 ± 27.120.948157.1 ± 16.62277.2 ± 42.970.002
ApoB (g/l)0.88 ± 0.020.77 ± 0.040.0190.87 ± 0.030.97 ± 0.040.090
ApoE (g/l)40.12 ± 0.9935.74 ± 1.800.03243.26 ± 1.4937.32 ± 1.880.037
FFA (pg/ml)0.41 ± 0.020.45 ± 0.040.2540.425 ± 0.0240.53 ± 0.050.041
IL-6 (pg/ml)4.60 ± 0.376.82 ± 1.020.0145.04 ± 0.427.38 ± 0.950.013
TNF-α (pg/ml)7.94 ± 0.428.05 ± 0.630.8947.32 ± 0.3829.01 ± 0.5530.037
(I + II) TNM stage no. (%)70 (55.6%)17 (35.6%)0.02351 (46.9%)14 (41.4%)0.660
  1. BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, LY Lymphocyte count, TP Total protein, ALB Albumin, PA Prealbumin, TC Total cholesterol, TG Tri-glyceride, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid